Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Recent publications
-
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study.
Journal article
Dave RV. et al, (2023), Breast cancer research and treatment, 199, 265 - 279
-
Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
Journal article
Clift AK. et al, (2023), BMJ, 381
-
Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England
Journal article
Gannon MR. et al, (2023), Cancer Epidemiology, 83
-
The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study.
Journal article
Miller K. et al, (2023), Clin Oncol (R Coll Radiol), 35, e265 - e277
-
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Journal article
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys